04 Apr, EOD - Indian

SENSEX 75364.69 (-1.22)

Nifty 50 22904.45 (-1.49)

Nifty Bank 51502.7 (-0.18)

Nifty IT 33511.4 (-3.58)

Nifty Midcap 100 50645.95 (-2.91)

Nifty Next 50 61468.7 (-2.59)

Nifty Pharma 20560 (-4.03)

Nifty Smallcap 100 15675.95 (-3.56)

04 Apr, EOD - Global

NIKKEI 225 33780.58 (-2.75)

HANG SENG 22849.81 (-1.52)

S&P 5141.56 (-5.09)

LOGIN HERE

companylogoSakar Healthcare Ltd

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : 538377 | NSE Symbol : SAKAR | ISIN : INE732S01012 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |


Chairman's Speech

Dear Shareholders,

A journey of a thousand miles begins with a single step. The long journey undertaken by Sakar Healthcare from its very inception to its present leading position as a pharmaceutical company in Gujarat serves as a testimony to this proverb. It has been a momentous journey in challenges, rich in triumphs, and relentless in pursuit of excellence.

As we step into the future themed "Elevating Value, Empowering Lives," we reflect upon how those principles have shaped our strategies and achievements. Much as the world beats the rhythm with the spirit of the Olympics, so are we to find a parallel of that pursuit for excellence within ourselves. Our team's hard work, never-give-up attitude, draws from the athletes' relentless pursuit toward the podium. It is in light of your unwavering support, coupled with our team's attitude, that we have built a very strong foundation for success.

Sakar Healthcare has shown superior financial performance with a strong CAGR of 17.41% in revenues from FY21 to FY24. The group revenues during FY24 were at INR 1,533 Mn with an EBITDA margin of ~25%. These financial strength outcomes further provide us power to support growth-oriented initiatives and to come up with exceptional value for shareholders.

One of the cornerstones of our strategy is this expansion into the oncology segment. This launch of a state-of-the- art oncology manufacturing facility, coupled with a robust R&D pipeline, places Sakar Healthcare at the forefront in this critical therapeutic area. A recent patent granted to us for IMATINIB and receipt of the EU GMP certification for our oncology unit mark major milestones accomplished in our journey.

We are dedicated to excellence in operation and innovation. The delivery of cytotoxics as oral liquids, HME-enhanced solubility anti-cancer products, and liposomal formulations are a testament to our relentless pursuit towards better patient outcomes.

Geographically, we have expanded our global footprint across key markets and are rapidly building further with a strong pipeline of new opportunities being explored. We take great pride in our partnerships and customer relationships built on trust.

Looking ahead, we believe that Sakar Healthcare is on sound ground to benefit from these unfolding opportunities and deliver long-term growth. We remain committed to ongoing innovation and sound financial performance, positioning us to deliver exceptional value to our shareholders, patients, and the communities we serve.

We thank you for your continued support and confidence in Sakar Healthcare as we continue to grow value and empower lives.

Sincerely,
San jay Shah
Chairman and Managing Director

   

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +